Medicare Enrolled
Dr. Maury Berger, MD
Hematology & Oncology · Ocala, FL
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Consulting-driven
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Berger from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Berger? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Berger
Dr. Maury Berger is a hematology & oncology in Ocala, FL, with 20 years in practice. Based on federal Medicare data, Dr. Berger performed 39,704 Medicare services across 2,168 unique beneficiaries.
Between the years covered by Open Payments, Dr. Berger received a total of $16,208 from 71 pharmaceutical and/or device companies across 406 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Berger is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice▲ Top 18% volume in FL$ $16,208 industry payments
Medicare Practice Summary
Medicare Utilization ↗39,704
Medicare services
Top 18% in FL for hematology & oncology
2,168
Unique beneficiaries
$6
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~1,985 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Filgrastim injection (Zarxio) for white blood cells | 15,600 | $0 | $2 |
| Darbepoetin injection (Aranesp) for anemia | 12,200 | $2 | $21 |
| Iron infusion (Monoferric) | 3,100 | $17 | $72 |
| Denosumab injection (Prolia/Xgeva) | 3,000 | $18 | $69 |
| Complete blood count (CBC) with differential | 1,016 | $8 | $35 |
| Blood draw (venipuncture) | 991 | $8 | $19 |
| Comprehensive metabolic blood panel | 695 | $10 | $62 |
| Office visit, established patient (20-29 min) | 456 | $63 | $148 |
| Dexamethasone injection (steroid) | 282 | $0 | $1 |
| Anti-nausea injection (Aloxi/palonosetron) | 250 | $1 | $122 |
| Iron level test | 243 | $6 | $26 |
| Iron binding capacity test | 243 | $9 | $34 |
| Ferritin level test (iron stores) | 239 | $13 | $58 |
| Drug injection, under skin or into muscle | 210 | $10 | $93 |
| Injection of additional new drug or substance into vein | 119 | $11 | $105 |
| Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 | 100 | $20 | $124 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 85 | $44 | $304 |
| Antibody identification test, platelet associated immunoglobulin assay | 75 | $12 | $155 |
| Measurement of substance using immunoassay technique | 72 | $17 | $181 |
| Nephelometry, test method using light | 72 | $13 | $176 |
| Administration of chemotherapy into vein, 1 hour or less | 66 | $94 | $686 |
| Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | 50 | $1 | $19 |
| Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | 49 | $15 | $97 |
| Office visit, established patient (30-39 min) | 47 | $88 | $224 |
| Vitamin B-12 level test | 45 | $15 | $74 |
| Folic acid level test | 44 | $14 | $71 |
| Carcinoembryonic antigen (cea) protein level | 38 | $19 | $96 |
| Lactate dehydrogenase (enzyme) level | 37 | $6 | $30 |
| Injection, diphenhydramine hcl, up to 50 mg | 37 | $1 | $7 |
| Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 30 | $50 | $205 |
| Infusion into a vein for hydration, 31-60 minutes | 27 | $22 | $249 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 27 | $22 | $152 |
| New patient office visit (30-44 min) | 25 | $71 | $219 |
| Infusion, normal saline solution, sterile (500 ml = 1 unit) | 25 | $1 | $19 |
| Administration of chemotherapy into vein, each additional hour | 23 | $19 | $156 |
| Administration of additional new drug or substance into vein, 1 hour or less | 23 | $50 | $334 |
| Office visit, established patient (10-19 min) | 18 | $42 | $88 |
| Irrigation of implanted venous access drug delivery device | 17 | $16 | $111 |
| Collection of blood sample from implanted device | 14 | $20 | $64 |
| New patient office or other outpatient visit, 15-29 minutes | 14 | $45 | $152 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
8.3% high complexity
80.3% medium
11.4% routine
Industry Payment Transparency
Open Payments through 2024 ↗$16,208
Total received (2018-2024)
Avg $2,315/year across 7 years
Top 29% in FL for hematology & oncology
71
Companies
406
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$8,587 (53.0%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$6,643 (41.0%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$978 (6.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$975
2023$1,157
2022$1,190
2021$538
2020$2,103
2019$1,631
2018$8,615
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
PFIZER INC.
$4,512
AstraZeneca Pharmaceuticals LP
$3,489
Kite Pharma, Inc.
$1,343
Janssen Biotech, Inc.
$627
Amgen Inc.
$530
Novartis Pharmaceuticals Corporation
$506
Lilly USA, LLC
$360
Seagen Inc.
$359
Astellas Pharma US Inc
$312
Seattle Genetics, Inc.
$261
EMD Serono, Inc.
$236
Celgene Corporation
$220
Puma Biotechnology, Inc.
$210
Merck Sharp & Dohme Corporation
$201
Genentech USA, Inc.
$199
Incyte Corporation
$178
E.R. Squibb & Sons, L.L.C.
$164
Pharmacyclics LLC, An AbbVie Company
$154
Gilead Sciences, Inc.
$142
BeiGene USA, Inc.
$138
GENZYME CORPORATION
$134
Ipsen Biopharmaceuticals, Inc
$133
Ethicon US, LLC
$101
Novocure Inc.
$89
Daiichi Sankyo Inc.
$82
Alexion Pharmaceuticals, Inc.
$79
Bayer HealthCare Pharmaceuticals Inc.
$78
JAZZ PHARMACEUTICALS INC.
$76
Rigel Pharmaceuticals, Inc.
$76
Mirati Therapeutics, Inc.
$65
Pharmacyclics LLC, an AbbVie Company
$60
TerSera Therapeutics LLC
$56
Takeda Pharmaceuticals U.S.A., Inc.
$53
Octapharma USA, Inc.
$53
Eisai Inc.
$48
Boehringer Ingelheim Pharmaceuticals, Inc.
$47
GlaxoSmithKline, LLC.
$44
ARRAY BIOPHARMA INC
$42
MEDIVATION FIELD SOLUTIONS LLC
$40
Exelixis Inc.
$37
Lexicon Pharmaceuticals, Inc.
$35
SOBI, INC
$34
Sun Pharmaceutical Industries Inc.
$34
Apellis Pharmaceuticals, Inc.
$32
Horizon Therapeutics plc
$32
Clovis Oncology, Inc.
$30
ABBVIE INC.
$29
Helsinn Therapeutics (U.S.), Inc.
$28
Amneal Pharmaceuticals LLC
$25
Fennec Pharmaceuticals, Inc.
$24
Agios Pharmaceuticals, Inc.
$24
Tempus AI, Inc
$23
Bayer Healthcare Pharmaceuticals Inc.
$23
ADC Therapeutics America, Inc.
$22
MorphoSys, US Inc.
$21
Pharmacosmos Therapeutics Inc.
$20
Medtronic, Inc.
$20
G1 Therapeutics, Inc.
$19
SERVIER PHARMACEUTICALS LLC
$19
TESARO, Inc.
$18
GE HealthCare
$18
CTI BioPharma Corp.
$17
Karyopharm Therapeutics Inc.
$17
Epizyme, Inc.,
$16
Regeneron Healthcare Solutions, Inc.
$16
Shire North American Group Inc
$15
Taiho Oncology, Inc.
$14
Coherus Biosciences Inc.
$14
Blueprint Medicines Corporation
$14
AbbVie Inc.
$12
Foundation Medicine, Inc.
$11
Top 3 companies account for 57.7% of total payments
Associated products mentioned in payments ›
ABECMA · ADAKVEO · ADCETRIS · AKYNZEO · ALIMTA · AVASTIN · AYVAKIT · Alecensa · Aliqopa · Aranesp · Avastin · BAVENCIO · BOSULIF · BRAFTOVI · BRUKINSA · Bavencio · CALQUENCE · CERTUS 140 MICROWAVE ABLATION SYSTEM · COSELA · CYRAMZA · Cabometyx · DARZALEX · Doptelet · ELAHERE · ELITEK · ELREXFIO · EMPRINT · ENHERTU · ENJAYMO · ERBITUX · ERLEADA · Empaveli · Enhertu · Erleada · FOUNDATIONONE · Fabhalta · GAZYVA · GILOTRIF · IBRANCE · IMBRUVICA · IMFINZI · INFLECTRA · INJECTAFER · INLYTA · Imbruvica · Inrebic · JAKAFI · JEVTANA · KANJINTI · KEYTRUDA · KISQALI · KRAZATI · KRYSTEXXA · Kadcyla · Kyprolis · LIBTAYO · LUMAKRAS · LYNPARZA · Lenvima · Lonsurf · MEKINIST · MONJUVI · MYLOTARG · NERLYNX · Nerlynx · Nplate · Nubeqa · OCREVUS · OCTAGAM IMMUNE GLOBULIN (HUMAN) · ODOMZO · ONUREG · OPDIVO · OXBRYTA · Onivyde · Optune Lua (NovoTTF-200T) · PADCEV · PANZYGA · PIQRAY · PLUVICTO · PROMACTA · PROSTATE CANCER - DISEASE · Padcev · Pedmark · Pomalyst · Prolia · Quzyttir · REBLOZYL · RYBREVANT · RYDAPT · Revlimid · Rezlidhia · Rubraca · SOLIRIS · SUTENT · Somatuline Depot · TAGRISSO · TASIGNA · TAZVERIK · TECENTRIQ · TEVIMBRA · TIBSOVO · TIVDAK · TUKYSA · Tavalisse · Trodelvy · ULTOMIRIS · Udenyca · Ultomiris · VENCLEXTA · VERZENIO · VOTRIENT · Vitrakvi · Vonjo · XALKORI · XOSPATA · XPOVIO · XT CDX · XTANDI · Xermelo · Xospata · Xtandi · YONSA · Yescarta · ZEJULA · ZEPZELCA · ZOLADEX
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (53%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers.
Equivalent to $41 per 100 Medicare services performed
Geographic Context
Hematology & Oncologys within 10 mi
6
Per 100K population
1.5
County median income
$58,535
Nearest hospital
ADVENTHEALTH OCALA
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Berger is a mixed practice specialist, with above-average Medicare volume (top 18% in FL), and consulting-driven industry engagement, with 20 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Berger experienced with filgrastim injection (zarxio) for white blood cells?
Based on Medicare claims data, Dr. Berger performed 15,600 filgrastim injection (zarxio) for white blood cells services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Berger receive payments from pharmaceutical companies?
Yes. Dr. Berger received a total of $16,208 from 71 companies across 406 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Berger's costs compare to other hematology & oncologys in Ocala?
Dr. Berger's average Medicare payment per service is $6. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Berger) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncologys in Ocala
Browse hematology & oncologys in Ocala ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncologys in FL
Hematology & Oncologys ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncologys in FL
Which FL hematology & oncologys receive the most from drug and device companies.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC..
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Kite Pharma, Inc. Payments to Doctors
See all physicians who received payments from Kite Pharma, Inc..
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology